Abstract
The antiretroviral nanoparticle formulation laboratory at Creighton University School of Pharmacy & Health Professions is lead by Chris Destache. Over the past 4 years, this laboratory has been investigating the use of antiretroviral nanoparticles as a sustained drug delivery method for HIV-1-infected patients.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 383-386 |
| Number of pages | 4 |
| Journal | Therapeutic delivery |
| Volume | 1 |
| Issue number | 3 |
| DOIs | |
| State | Published - Sep 1 2010 |
All Science Journal Classification (ASJC) codes
- Pharmaceutical Science
Fingerprint Dive into the research topics of 'Antiretroviral nanoparticles: An extended drug delivery modality'. Together they form a unique fingerprint.
Cite this
Destache, C. J., Goede, M., & Belgum, T. (2010). Antiretroviral nanoparticles: An extended drug delivery modality. Therapeutic delivery, 1(3), 383-386. https://doi.org/10.4155/tde.10.42